| ID | 10138 |
| Vaccine Name | RotaTeq (RV5) |
| Disease Name | Rotavirus Infection |
| Disease Classification | Gastrointestinal |
| Virus Name | Rotavirus |
| Nucleic Acid Content | double stranded RNA |
| Vaccine Type | Live-attenuated |
| Vaccine Status | Approved |
| Manufacturer | Merck & Co. Inc. |
| Year of Manufacturing | NA |
| Manufacturing Country | USA |
| Age | 6 months - 8 months |
| Dosage | 3 doses at age of 2 months, 4 months, and 6 months |
| Administration Route | Oral |
| Adjuvant | NA |
| Target Strain | 5 human-bovine reassortant rotaviruses (G1, G2, G3 G4, P[8]) |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://www.cdc.gov/vaccines/vpd/rotavirus/index.html |
| Additional Links | https://www.fda.gov/media/75718/download
|